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INTRODUCTION: The purpose of this ex vivo study was to determine the releasing characteristics 
and doxycycline dentinal diffusion of AH26 sealer-doxycycline combination from apical 3mm of 
tooth root and apical foramen. 
MATERIALS & METHODS: One-hundred and two recently extracted single-rooted human teeth 
were decoronated and prepared with #3 and #4 Gates-Glidden drills and rotary Mtwo files. Smear 
layer was removed; all surfaces except for apical 3mm of each root were sealed with two coats of 
nail polish. To quantify the release and diffusion of the doxycycline at different time intervals (30 
min, 48 and 72 h) after root canal obturation, the samples were randomly divided into three groups 
(n=30; 0.5 h, 48 h, 72 h). To evaluate the release of doxycycline from AH26 sealer-doxycycline 
combination at six concentrations of antibiotic including 0.5%, 1%, 2%, 5%, 10% and 20%; each 
experimental group was divided into six equal subgroups (n=5). Root canals were filled with 
gutta-percha and AH26-doxycycline combinations and then were placed in vials containing 
1.25mL of phosphate buffer saline solution (PBS). After 30 min, 48 and 72 h, the amount of 
doxycycline released from specimens into PBS were determined by measuring the absorbance 
values using UV spectrophotometry at λmax=350 nm. Data were analyzed using two-way ANOVA.  
RESULTS: The findings of this study revealed that AH26 sealer-doxycycline combination 
released variable measures of antibiotic at each time interval and in the various concentrations. At 
30 min, no statistically significant differences were obtained between the results of subgroups, but 
at 48 and 72 h these differences were significant (P<0.001). The results also showed that 
differences between 0.5 h, 48 h and 72 h were significant within subgroups (P<0.01). 
CONCLUSION: Under the conditions of this ex vivo study, doxycycline can be released from 
AH26 sealer-antibiotic combination through 3mm of apical root and apical foramen at 30 min, 48 
and 72 h after mixing the sealer with doxycycline at concentrations of 0.5% up to 20%.  
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INTRODUCTION 
Bacteria and their by-products are considered 
to be the most common causes of pulpal 
necrosis and periapical lesions. In the majority 
of teeth requiring root canal treatment, the goal 
is either prevention or treatment of apical 
periodontitis, or more precisely, prevention or 
elimination of a microbial infection in the root 
canal system (1). 
Within the last few years, antibiotics have been 
used for patients in dentistry systemically and 
topically. Chronic periradicular lesions associa-
ted with necrotic pulp do not have adequate 
blood supply. So when systemic antibiotic 
treatment is being used, the concentration of 
antibiotics that reach root canal system is 
negligible and not beneficial (2). Systemically 
administered antibiotics also can have some 
complications such as toxicity, allergic reactions 
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and development of resistant strains of micro-
organisms (3). It has been reported that the main 
advantage of local antibiotics compared to 
systemic use is absence of systemic complica-
tions; therefore, substantially higher concentra-
tions of antibiotics can be used (4). 
Also, the filling of a prepared root canal with an 
antimicrobial medicament allows the antibiotic to 
diffuse through the dentin, the canal irregularities 
and also into the periapical tissues. This then 
exposes the bacteria present in these areas to the 
medicaments and can enhance repair of a 
periapical lesion by reducing the number of active 
bacteria and/or other effects of medicaments such 
as anticollagenase and anti-resorptive activity of 
several antibiotics (e.g. tetracycline) (5). 
Tetracyclines’, including tetracycline HCl, 
minocycline, demeclocycline and doxycycline, 
are a group of broad spectrum antibiotics that are 
effective against a wide range of microorganisms. 
Tetracyclines also have many additional 
properties, such as the inhibition of mammalian 
collagenases so that prevent tissue breakdown, 
and the inhibition of clastic cells so they provide 
anti-resorption result. Inflammatory diseases such 
as periodontitis include an excess of tissue 
collagenases, which may be blocked by 
tetracyclines, thus leading to enhanced formation 
of collagen and bone (5). 
AH26 is an epoxy resin root canal sealer that 
initially was developed as a single-filler material. 
Because of its positive handling characteristics, it 
has been extensively used as a sealer. It has 
favorable flow, adaptation to dentinal walls, and 
working time (6). Like most sealers, AH26 is 
very toxic when freshly prepared. However, its 
toxicity declines rapidly during setting reaction 
and has the lowest toxicity among endodontic 
sealers after 24 h (7). 
There are few studies that have assessed the 
incorporation of antibiotics to endodontic 
sealers; they have evaluated the antimicrobial 
effects of antibiotic-sealer combinations against 
Enterococcus faecalis and physicomechanical 
properties of AH26/antibiotic combination (8-10). 
The purpose of this ex vivo study was to 
determine the release of doxycycline from 
AH26 sealer-doxycycline combination through 
apical 3mm of root and apical foramen.  
MATERIALS & METHODS 
One hundred and two recently extracted 
straight single-rooted human teeth with 
approximately same dimensions were selected 
and stored in saline solution. These teeth had 
the following characteristics: single canal, no 
fractures or caries, root resorption and open 
apices. The teeth were decoronated using 
diamond disks (D&Z, Berlin, Germany) to 
obtain a standardized root length of 14mm. 
The root canal of each tooth was explored 
using a size 10 or 15 K-file (Dentsply, 
Maillefer ,Tulsa, OK, USA) until the apical 
foramen was reached and the tip of the file 
was visible. The actual canal length was 
determined and WL was established by 
subtracting 1mm from this measurement. 
After coronal flaring with #3 and #4 Gates-
Glidden drills (Dentsply, Maillefer, Tulsa, 
OK, USA), instrumentation was completed 
with Mtwo rotary files (VDW, Munich, 
Germany) up to file size 40 in a step-back 
technique. A K-file size 10 was used to ensure 
apical patency between each file. Canals were 
irrigated with 5.25% NaOCl throughout the 
instrumentation. Then, a K-file size 30 was 
introduced into the root canal until the file tip 
was visible (standardization of apical 
foramen) and then canals were irrigated with 
1mL of 17% EDTA for 1min and 1mL of 
5.25% NaOCl to remove the smear layer. 
Finally, root canals were dried with paper 
points. All surfaces except for the apical 3mm 
of root were sealed with two coats of nail 
polish.  
In order to quantify the release and diffusion of 
the doxycycline at different times (30 min, 48 
and 72 h) after root canal obturation, the 
samples were randomly divided into three 
groups of 30 specimens (0.5 h, 48 h, 72 h) For 
evaluating the release of doxycycline from 
AH26 sealer-doxycycline combination at six 
concentrations of 0.5% (DX0.5), 1% (DX1), 
2% (DX2), 5% (DX5), 10% (DX10), 20% 
(DX20) of antibiotic, each experimental group 
was divided into six equal subgroups (n=5). At 
each time period, three specimens were 
obturated with AH26 sealer (Dentsply, DeTrey, 
Konstanz, Germany) and gutta-percha (control 
group 1) and one tooth was not obturated 
(control group 2). 
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Table 1. Mean (±SD) values of RDX (Concentration) in each experimental group as μg/mL and μg/1.25mL
 
RDX (μg/mL) RDX (μg/1.25mL) 
   Time 
DX  
30 min 48 h 72 h  
 
30 min 48 h 72 h  
0.5% 2.270 (±1.40) 2.899 (±1.64) 0.983 (±1.20) 2.837 (±1.75) 3.624 (±2.05) 1.229 (±1.50) 
1% 2.312 (±0.82) 2.245 (±1.66) 0.944 (±1.23) 2.890 (±1.02) 2.806 (±2.07) 1.181 (±1.57) 
2% 1.681 (±0.78) 2.867 (±1.44) 1.233 (±1.29) 2.102 (±0.97) 3.58 (±1.8) 1.542 (±1.61) 
5% 2.410 (±1.10) 6.554 (±2.17) 3.212 (±1.98) 3.013 (±1.37) 8.192 (±2.71) 4.015 (±2.47) 
10% 2.008 (±0.88) 6.467 (±2.44) 5.328 (±2.15) 2.510 (±1.1) 8.084 (±3.05) 6.661 (±2.68) 
20% 1.691 (±1.48) 7.575 (±1.87) 7.402 (±2.96) 2.113 (±1.85) 9.468 (±2.33) 9.252 (±3.7) 
 
Doxycycline (Iran Daru, Tehran, Iran) was 
added separately to the powder of AH26 sealer 
(Dentsply, DeTrey, Konstanz, Germany) in each 
concentration and mixed with liquid of sealer 
according to manufacturers’ specifications. Then 
the root canals were filled with gutta-percha and 
AH26-doxycycline combinations; gutta-percha 
was removed up to 2mm below the orifices and 
the spaces were sealed with glass ionomer filling 
material (Fuji IX, GC Co., Tokyo, Japan) and 
were then covered with dental adhesive wax. 
After this stage, specimens were placed in 
1.5mL eppendorf vials containing 1.25mL of 
phosphate buffered saline (PBS) and then roots 
were stored vertically at room temperature. 
After 30 min, 48 and 72 h the amounts of 
doxycycline released from specimens to PBS 
were determined by measuring the absorbance 
values using UV spectrophotometry at 
λmax=350nm. The apparatus was calibrated at 
zero absorbance by using PBS as blank. The 
details for these steps are exampled below: 
Graphing the standard curve of doxycycline 
A standard curve is a graph relating a measured 
quantity (spectrophotometry, for example) to 
concentration of the substance of interest in 
"known" samples. 
Preparation of standard stock solution 
A standard stock solution of doxycycline was 
prepared by weighing 10mg of the drug and 
dissolving this in 100mL distilled water. The 
stock solution was diluted in the concentration 
range of 1-50μg/mL with distilled water to 
obtain the concentration ranges required. 
Determination of λmax 
To determine the λmax of doxycycline 
(wavelength that maximum absorption 
occurred), two concentration of prepared 
solutions was assessed by UV 
spectrophotometry. The value of λmax for 
doxycycline was determined at 350nm. The 
amount of doxycycline dissolved in each 
sampled solution was determined by UV 
spectrophotometry (JASCO Co. Ltd., Tokyo, 
Japan) at λmax. 
The standard curve was drawn by plotting 
absorbance (on the Y axis) vs. concentration (on 
the X axis). Such a curve can be used to 
determine concentrations of the doxycycline in 
"unknown" samples. The points on the calibration 
curve should yield a straight line (regression 
line). To validate the standard curve, this 
procedure was repeated three times on the same 
day and another two times on two different days. 
To eliminate or reduce the interfering factors 
with absorbance, the final absorbance was 
calculated from these data after the control 
group absorbance was subtracted. The 
absorbance of the doxycycline was then used 
with the slope and intercept from the calibration 
curve to calculate the concentration of the 
doxycycline (μg/mL). These concentrations 
(RDX) were also reported as μg per 1.25mL. 
All of this procedure was repeated three times 
and the mean values of doxycycline 
concentration were calculated for each 
experimental group. 
Two-way analysis of variance (ANOVA) was 
used in testing the effect of time, antibiotic 
concentration, and their interactions on 
doxycycline release. The level of significance 
was set at P<0.05. 
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Figure 1. Standard curve of doxycycline 
RESULTS 
Figure 1 shows the standard curve of 
doxycycline that has been drawn by plotting 
absorbance (Y axis) vs. concentration (X axis). 
The linearity of the calibration curve for 
doxycycline over the concentration range 1-
100μg/mL demonstrated a correlation 
coefficient of 0.9995. 
Specimens of control group 1 showed some 
degrees of UV absorbance at λmax=350nm; 
however, this was not observed in PBS 
obtained from control group 2. 
Table 1 shows the mean values of doxycycline 
that were released in each experimental group 
RDX) as μg/mL and μg/1.25mL and their 
standard deviations. 
Figure 2 shows the ex vivo release of 
doxycycline at different times. 
Split on time 
At 30 min, no statistically significant 
differences between the results of subgroups 
(DX0.5, DX1, DX2, DX5, DX10 and DX20) 
were obtained (P=0.298) but at 48 and 72 h 
these differences were significant (P<0.001). 
At 48 h, there were no significant differences 
between results of DX0.5, DX1 and DX2 
(P>0.05), also no statistically significant 
differences were found between the results 
obtained from DX5, DX10 and DX20 (P>0.05), 
but differences between results of any of 
former subgroups with any of latter subgroups 
were significant (P<0.05). 
At 72 h, there were no statistically significant  
Figure 2. The ex vivo release of doxycycline at different 
times from AH26-doxycycline combination in six 
concentration 
differences among the DX0.5, DX1 and DX2 
(P>0.05), but significant differences in RDX 
were found between any of DX0.5 and DX1 
subgroups with any of DX5, DX10 and DX20 
subgroups (P<0.05). The results showed no 
significant difference between the DX2 and 
DX5 (P>0.05) whereas the results of DX2 with 
DX10 and DX2 with DX20 had significant 
differences (P<0.05). No significant difference 
was seen between results of DX5 and DX10 
(P>0.05) but difference between DX5 and 
DX20 was significant (P<0.05). No statistically 
significant difference between the results of 
DX10 and DX20 was obtained (P>0.05). 
Split on DX 
The results of this study showed that in any of 
subgroups i.e. DX0.5 (P=0.002), DX1 
(P=0.008), DX2 (P=0.002), DX5, DX10 and 
DX20 (P<0.001) differences between T0.5, 
T48 and T72 were significant. 
In subgroup DX0.5, the result of T72 was 
significantly lower than that of T0.5 and T48 
(P<0.05). However, there was no significant 
difference between RDX of T0.5 and T48 
(P>0.05). 
In subgroup DX1, only the difference T0.5 and 
T72 was significant (P<0.05). 
In subgroups DX2 and DX5, the result of T48 
was significantly higher than T0.5 and T72 
(P<0.05), whereas difference between T0.5 and 
T72 was not significant (P>0.05). 
In subgroups DX10 and DX20, the result of 
T0.5 was significantly lower than T48 and T72 
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(P<0.05), but no significant difference was seen 
between the results of T48 and T72 (P>0.05). 
DISCUSSION  
One of the key goals of endodontic therapy is 
complete obturation of the root canal system. 
The success of obturation is directly dependent 
on the elimination of microorganisms through 
mechanical cleaning and shaping, supplemented 
by antibacterial irrigant, adequate filling of the 
root canal system, and use of antimicrobial 
medicaments between appointments, if 
necessary. However, these procedures do not 
result in complete sterility of the root canal 
space (11). Therefore, antimicrobial agents are 
added to the root canal sealers to improve their 
antibacterial activity. The antibacterial 
properties of sealers may also be advantageous 
in cases of persistent or recurrent infection (12).  
AH26 was chosen as the test sealer because of 
its easy handling characteristics, good flow, 
good sealing to dentin, sufficient working time 
(7), prominent antimicrobial activity (13,14) 
and optimal depth of penetration into dentinal 
tubules in clinical situations (15). 
Antiseptics are very effective antimicrobial 
agents but they also tend to kill mammalian cells 
at similar concentrations that kill micro-
organisms. This toxicity is time dependent so 
their use should be limited to short-term contact. 
Antibiotics are less toxic to mammalian cells at 
effective concentrations and they are not suitable 
for short-term use (2).  
Tetracyclines (such as doxycycline) are 
substantive due to their hard tissue binding 
capability and also have an innate anti-
resorptive action. They have the ability to bind 
to the tooth surface and then be slowly released 
in active form. Tetracyclines also promote 
fibroblast and connective tissue attachment, 
enhancing regeneration of periodontal 
attachment lost to pathologic process. 
Tetracyclines inhibit the activity of collagenase 
and also the function of the osteoclast. Their 
effects on the osteoclast include diminished 
acid production, decreased ruffled border area 
and decreased adhesive properties, all of which 
inhibit bone resorption (16). Doxycycline was 
assessed in current study because of these 
advantageous properties along with its 
antimicrobial activity.  
In this study, the concentration of the 
doxycycline released into PBS was evaluated 
by UV spectrophotometry. In many studies this 
method has been used successfully to 
determine doxycycline (17-23). 
In the present study, the doxycycline release was 
evaluated at 30 min, 48 and 72 h after obturation 
of root canals. In our pilot study, the setting time 
of AH26 sealer-doxycycline combination was 
increased and found to be about 50 h these times 
(30 min, 48 and 72 h) were selected on the basis 
of pilot data. 
The amount of doxycycline that should be 
added to sealer was determined according to 
results of two previous studies (8,9) and our 
pilot experiment. 
Varying degrees of UV absorbance were 
observed in control group 1. This finding was 
because of the low specificity of UV 
spectrophotometry in determination of 
doxycycline in solutions that two or more 
interfering components with overlapped 
absorption bands are available in them (24). The 
interfering factor may be formaldehyde that is 
released from sealer into PBS (25). In our study, 
to eliminate or reduce the interfering factors with 
absorbance, the final absorbance was calculated 
from data of experimental groups after the control 
group’s absorbance were subtracted (26).  
The result of our study revealed that in 0.5 h, 
differences between any of subgroups were not 
significant. The shortest evaluation time after 
obturation was 30 min and in this time the 
amount of doxycycline that was available in 
sealer could not be very drastic variable, but in 
T48 and T72 there were sufficient time for this 
variable to make difference between RDX of 
subgroups. 
Our results did not reveal a completely similar 
pattern of increase in subgroups and this 
finding might be attributed to differences 
between specimens from aspects of tooth age, 
dentinal tubule diameter, number of lateral 
canal that are present in apical 3mm of root and 
presence or absence of cementum (22,23). 
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The results of this study also showed that in any 
of subgroups, differences between T0.5, T48 and 
T72 were significant. In any amount of DX, 
RDX increased from 30 min to 48 h and then 
decreased. This finding may be attributed to 
balance between the amount of release and 
stability of drug in PBS (27). Furthermore, it is 
logical that the release of drug decreases after 
setting of sealer. It should be kept in mind that in 
current study, specimens were separately placed 
in PBS and the release of drug was not evaluated 
in one specimen over time.  
Additionally, the hard tissue-binding capability 
of doxycycline should be considered as a 
potential factor that can influence the release 
characteristics of drug. No data are available 
about the range of time that maximum binding 
is occurred. 
Nevertheless, it is important to note that 
doxycycline is one of the most
 
stable tetra-
cycline group members and a good candidate 
for slow release
 
formulations (27).  
Abbott et al. showed that the rate of demeclo-
cycline release from ledermix paste was highest 
during the first day and declined exponentially 
with time thereafter (22). These findings are in 
agreement with our study. 
In many studies, the antimicrobial suscepti-
bilities of pathogens isolated from odontogenic 
and periodontal infections were determined. 
Slots et al. reported that minimum inhibitory 
concentrations (MICs) of doxycycline for 
periodontal pathogens were lower than 6μg/mL 
(28). However, Solvi et al. stated that 
susceptibilities of periodontal pathogens to 
doxycycline were in the range of 0.1-2μg/mL 
(29). In another study, Mosca et al. evaluated the 
antimicrobial susceptibility of Prevotella spp. 
And Fusobacterium nucleatum isolated from 
patients with periodontal disease (30). MIC90 of 
doxycycline for F nucleatum, P intermedia, P 
bucca and P melanogenica were 0.38, 0.094, 
0.094 and 4μg/mL, respectively. In a study by 
Norris and Love, the antimicrobial suscepti-
bilities of three Porphyromonas spp to 
doxycycline were determined 8μg/mL (31). 
Carson et al. evaluated the antimicrobial activity 
of six irrigants on primary endodontic pathogens 
(32). They found that MICs of doxycycline for 
all organisms tested (Peptostereptococcus 
micros, Prevotella intermedia, Stereptococcus 
sanguis and Lactobacillus acidophilus) were 
below 0.78μg/mL. LeCorn et al. studied the 
activity of several antibiotics against oral 
Actinomyces (33). The MIC90 was 0.25μg/mL 
for doxycycline. They stated that the 
incorporation of these antimicrobial agents into 
the periradicular tissues through the root canal or 
as an intracanal irrigant may be effective in 
sterilizing lesions of endodontic origin, thus 
decreasing failure due to infection by Actinomy-
ces. According to the results of the mentioned 
studies (28-33), it might be concluded that the 
RDXs in many of subgroups especially in DX5, 
DX10 and DX20 inhibit majority of pathogens 
that are involved in odontogenic infections. 
In addition, fungi may be involved in cases of 
persistent and secondary periradicular lesions, the 
spectrum of antimicrobial activity of endodontic 
medicaments and irrigants should include these 
microorganisms. Himani et al. resulted that the 
doxycycline hydrochloride can be used effect-
ively against Candida albicans (34). 
In comparison of RDXs with MICs of 
doxycycline it should be considered that, 
according to many studies, MICs for planktonic 
microorganisms are not reliable predictors of the 
effects of doxycycline against their biofilms (35). 
The inhibition of bone resorption by 
doxycycline occurs even when a low sub-
antimicrobial dose is administered. Interestingly, 
chemically modified types of tetracyclines 
which lack any antibacterial effects are still 
effective in the inhibition of bone resorption (36). 
The use of antibiotics as an intracanal 
medicament or irrigant may have potential side 
effects including crown discoloration, 
development of resistant bacterial strains, and 
allergic reaction (37). Clinical and 
experimental studies have confirmed that 
different types of tetracycline, when use as 
intracanal medicaments (ledermix paste and 
triple antibiotic mixture) or irrigant (MTAD), 
cause varying degrees of discoloration (38-40). 
Thus, incorporation of doxycycline to sealer 
might result in staining of teeth but such effects 
can be minimized if placement of the sealer is 
restricted to below the gingival margin. 
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Furthermore, the physicomechanical properties 
of endodontic sealers might be affected by 
adding antibiotics. Accordingly, Razmi et al. 
showed that adding amoxicillin or doxycycline 
at concentration of 1% to AH26 sealer led to a 
decrease in flow of the sealer, changes in 
setting time of AH26 i.e. decrease in setting 
time with amoxicillin and increase with 
doxycycline, increase in film thickness, 
increase in the dimensional changes following 
setting, and increase in the solubility of the 
sealers (10). However, all changes were still 
within the BS EN ISO 6876 (2001) standards. 
CONCLUSION 
In conclusion, under the conditions of this ex 
vivo study, doxycycline can be released from 
AH26 sealer-antibiotic combination through 
3mm of apical root and apical foramen at 30 
min, 48 and 72 h after mixing the sealer with 
doxycycline at concentrations of 0.5%, 1%, 
2%, 5%, 10%, 20%. The AH26 sealer-
antibiotic combination is not clinically 
approved to use in root canal treatment. This 
mixture could change the positive 
specification of AH26, such as 
biocompatibility, sealing ability, etc. Further 
studies are needed to evaluate the effect of 
antibiotic on biocompatibility as well as 
sealing properties of an endodontic sealer. 
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